Retrieve available abstracts of 17 articles: HTML format
Single Articles
September 2025
KONECNA K, Prerovska T, Loja T, Fajkusova L, et al Functional characterization of 16 variants found in the LDL receptor gene.
J Lipid Res. 2025;66:100873. PubMedAbstract available
February 2025
PENG X, Lian Z, O'Brien V, Xiao J, et al Foamy monocytes and atherogenesis in mice with combined hyperlipidemia and
effects of antisense knockdown of apoCIII.
J Lipid Res. 2025 Feb 21:100763. doi: 10.1016/j.jlr.2025.100763. PubMedAbstract available
January 2025
WESTBYE AB, Dizdarevic LL, Dahl SR, Asprusten EA, et al A sterol panel for rare lipid disorders: sitosterolemia, cerebrotendinous
xanthomatosis and Smith-Lemli-Opitz syndrome.
J Lipid Res. 2025;66:100698. PubMedAbstract available
November 2024
DUDDU S, Katakia YT, Chakrabarti R, Sharma P, et al New Epigenome Players in the Regulation of PCSK9 - H3K4me3 and H3K9ac Alteration
by Statins in hypercholesterolemia.
J Lipid Res. 2024 Nov 18:100699. doi: 10.1016/j.jlr.2024.100699. PubMedAbstract available
LA CHICA LHOEST MT, Martinez A, Garcia E, Dandurand J, et al ApoB100 Remodeling and Stiffened Cholesteryl Ester Core Raise LDL Aggregation in
Familial Hypercholesterolemia Patients.
J Lipid Res. 2024 Nov 16:100703. doi: 10.1016/j.jlr.2024.100703. PubMedAbstract available
August 2024
JIN Y, Kozan D, Young ED, Hensley M, et al A high-cholesterol zebrafish diet promotes hypercholesterolemia and
fasting-associated liver steatosis.
J Lipid Res. 2024 Aug 30:100637. doi: 10.1016/j.jlr.2024.100637. PubMedAbstract available
July 2024
BARDEY F, Rieck L, Spira D, Marz W, et al Clinical characterization and mutation spectrum of patients with
hypertriglyceridemia in a German outpatient clinic.
J Lipid Res. 2024 Jul 3:100589. doi: 10.1016/j.jlr.2024.100589. PubMedAbstract available
LI C, Tian J, Liu N, Song D, et al MicroRNA-206 as a potential cholesterol-lowering drug is superior to statins in
mice.
J Lipid Res. 2024;65:100576. PubMedAbstract available
June 2024
YANG Y, Konrad RJ, Ploug M, Young SG, et al APOA5 Deficiency Causes Hypertriglyceridemia by Reducing Amounts of Lipoprotein
Lipase in Capillaries.
J Lipid Res. 2024 Jun 14:100578. doi: 10.1016/j.jlr.2024.100578. PubMedAbstract available
JIANG L, Gangireddy S, Dickson AL, Xin Y, et al Characterizing genetic profiles for high triglyceride levels in U.S. patients of
African ancestry.
J Lipid Res. 2024;65:100569. PubMedAbstract available
February 2024
CHACKERIAN B, Remaley AT PCSK9 Vaccines: A promising new strategy for the treatment of
hypercholesterolemia?
J Lipid Res. 2024 Feb 17:100524. doi: 10.1016/j.jlr.2024.100524. PubMed
VROOM MM, Lu H, Lewis M, Thibodeaux BA, et al VXX-401, a novel anti-PCSK9 vaccine, reduces LDL-C in cynomolgus monkeys.
J Lipid Res. 2024;65:100497. PubMedAbstract available
January 2024
SLIJKHUIS N, Razzi F, Korteland SA, Heijs B, et al Spatial Lipidomics of Coronary Atherosclerotic Plaque Development in a Familial
Hypercholesterolemia Swine Model.
J Lipid Res. 2024 Jan 19:100504. doi: 10.1016/j.jlr.2024.100504. PubMedAbstract available
December 2023
CHAPMAN MJ, Orsoni A, Mellett NA, Nguyen A, et al Statin treatment remodels the HDL subclass lipidome and proteome in
hypertriglyceridemia.
J Lipid Res. 2023 Dec 29:100494. doi: 10.1016/j.jlr.2023.100494. PubMedAbstract available
MEDEIROS AM, Alves AC, Miranda B, Chora JR, et al Unravelling the genetic background of individuals with a clinical Familial
Hypercholesterolemia phenotype.
J Lipid Res. 2023 Dec 18:100490. doi: 10.1016/j.jlr.2023.100490. PubMedAbstract available
JAMES JK, Norland K, Johar AS, Kullo IJ, et al Deep generative models of LDLR protein structure to predict variant
pathogenicity.
J Lipid Res. 2023;64:100455. PubMedAbstract available
July 2023
WANG Y, Kong L, Ye C, Dou C, et al Hypertriglyceridemic hyperapoB and the development and resolution of nonalcoholic
fatty liver disease: A cohort study.
J Lipid Res. 2023 Jul 20:100418. doi: 10.1016/j.jlr.2023.100418. PubMedAbstract available